ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

FDA Grants Accelerated Approval To Mekinist-Tafinlar Combination

January 31, 2014

NCCS Networker Volume 9 Issue 3, Summer 1995

June 12, 1995

Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment

June 25, 2004

NCI Signs Letters Of Intent With Latin American Countries

October 2, 2009

Lasker Official Urges Congressional Support Of NCI Bypass Budget

April 20, 1990